Cynthia Seidel-Dugan
No más puestos en curso
Fortuna: 1 M $ al 31/03/2024
Perfil
Cynthia Seidel-Dugan worked as the Chief Scientific Officer at Potenza Therapeutics, Inc. from 2018 to 2018.
Prior to that, she was the Vice President-Biology at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Currently, she is the Chief Scientific Officer at Werewolf Therapeutics, Inc. from 2019 to 2024.
Dr. Seidel-Dugan holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from The College of William & Mary.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/01/2024 | 164 888 ( 0.39% ) | 1 M $ | 31/03/2024 |
Antiguos cargos conocidos de Cynthia Seidel-Dugan.
| Empresas | Cargo | Fin |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29/03/2024 |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/12/2018 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/02/2014 |
Formación de Cynthia Seidel-Dugan.
| University of Pennsylvania | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Cynthia Seidel-Dugan
